“When 14-year-old Nick Wilkins’ leukemia resisted chemotherapy, radiation and a bone marrow transplant, his doctors turned to the real pros: Nick’s own immune cells,” John Bonifield of CNN recently wrote on Click2Houston.com. After two months of targeted immunotherapy, Nick’s cancer “went into complete remission.”
Nick’s experience was not unique. Eighteen of the 21 other young cancer patients participating in a University of Pennsylvania study on the effectiveness of immunotherapy-based advanced targeted therapies also experienced complete remission of their cancer.
“This is absolutely one of the more exciting advances I’ve seen in cancer therapy in the last 20 years,” Dr. David Porter, Penn hematologist and oncologist, told CNN. “We’ve entered into a whole new realm of medicine.”
While some of the approaches to targeted cancer therapy are certainly new – recent advances in cellular and genetic medicine have made it possible to target specific genes and cell functions at a level not previously available – employing the body’s immune system to target cancer is a tried and true, rather than a “new,” approach. Issels Integrative Oncology Centers have been using individualized immunotherapy to treat cancer for more than 60 years! (Learn more about Issels’ history.)
Penn cancer researchers are not the only ones belatedly recognizing the advantages the immune system offers in the fight against cancer. In an earlier post on targeted therapy, we quoted immunologist Gordon Freeman of Boston’s Dana-Farber Cancer Institute, who presaged the Penn findings when he said:
“The immune system is an evolutionary learning system. If you can engage it and get it to work successfully, it learns how to attack the cancer. And the wonderful thing is that it works.”
Visit our website to find out about integrative immunotherapy, a safe, effective, non-toxic way to treat cancer that is revolutionizing cancer treatment.